DSpace at RU >

Search Results

Results 1-50 of 197.

Item hits:

Full Text	Issue Date	Title	Author(s)
	2011	The times they are a-changin	Krieken, J.H. van
	2011	Crisis? What crisis?	Krieken, J.H. van
	2011	Book review: A pattern approach to lymh node diagnosis by Antony S-Y Leong	Krieken, J.H. van
	2011	Diagnostic pathology: lymph nodes and spleen with extranodal lymphomas	Krieken, J.H. van
	2011	New developments in the pathology of malignant lymphoma: a review of the literature published from November 2010-January 2011	Krieken, J.H. van
	2011	The first special issue of the Journal of Hematopathology	Krieken, J.H. van
	2011	Rising costs of health care and pathology: cause or solution	Krieken, J.H. van
	2011	New developments in the pathology of malignant lymphoma: a review of the literature published from February 2011-August 2011	Krieken, J.H. van
	2011	[Isolated tumour cells: 'seek, and ye shall find'].	Krieken, J.H.J.M. van
	2011	High prevalence of adverse prognostic genetic aberrations and unmutated IGHV genes in small lymphocytic lymphoma as compared to chronic lymphocytic leukemia.	Groenen, P.J.T.A.; Raymakers, R.; Rombout, P.D.M.; Prenter, M. de; Kossen, L.; Philipsen-Jansen, C.; Feuth, T.; Meijer, J.W.R.; Geurts van Kessel, A.H.M.; Krieken, J.H.J.M. van; Stevens-Kroef, M.J.P.L.
	2011	Rapid-growing tumor of the cheek mimicking a malignant tumor: lipoblastoma of infancy.	Dillingh, S.J.; Merkx, T.; Krieken, J.H.J.M. van; Ten, W.T.; Loo, D.M.W.M. te
	2011	Preparing pathology for personalized medicine: possibilities for improvement of the pre-analytical phase	Groenen, P.J.T.A.; Blokx, W.A.M.; Diepenbroek, C.; Burgers, L.; Visinoni, F.; Wesseling, P.; Krieken, J.H. van
	2011	Mutation analysis of KRAS prior to targeted therapy in colorectal cancer: development and evaluation of quality by a European external quality assessment scheme	Dequeker, E.; Ligtenberg, M.J.L.; Borght, S. van der; Krieken, J.H. van
	2011	Large variation between hospitals and pathology laboratories in lymph node evaluation in colon cancer and its impact on survival, a nationwide population-based study in the Netherlands	Elferink, M.A.; Siesling, S.; Visser, O.; Rutten, H.J.; Krieken, J.H. van; Tollenaar, R.A.E.M.; Lemmens, V.E.
	2011	External quality assessment for KRAS testing is needed: setup of a European program and report of the first joined regional quality assessment rounds	Bellon, E.; Ligtenberg, M.J.L.; Tejpar, S.; Cox, K.; Hertogh, G. de; Stricker, K.; Edsjo, A.; Gorgoulis, V.; Hofler, G.; Jung, A.; Kotsinas, A.; Laurent-Puig, P.; Lopez-Rios, F.; Hansen, T.P.; Rouleau, E.; Vandenberghe, P.; Krieken, J.H.J.M. van; Dequeker, E.
	2011	Variation in case-mix between hospitals treating colorectal cancer patients in the Netherlands	Kolfschoten, N.E.; Marang van de Mheen, P.J.; Gooiker, G.A.; Eddes, E.H.; Kievit, J.; Tollenaar, R.A.E.M.; Wouters, M.W.; Bemelman, W.A.; Busch, O.R.; Dam, R.M. van; Harst, E. van der; Jansen-Landheer, M.L.E.A; Karsten, T.M.; Krieken, J.H.J.M. van; Kuijpers, W.G.T.; Lemmens, V.E.; Manusama, E.R.; Meijerink, W.J.H.J.; Rutten, H.J.; Wiggers, T.; Velde, C.J. van de
	2011	Variation in lymph node evaluation in rectal cancer: a Dutch nationwide population-based study	Elferink, M.A.; Siesling, S.; Lemmens, V.E.; Visser, O.; Rutten, H.J.; Krieken, J.H. van; Tollenaar, R.A.E.M.; Langendijk, J.A.
	2011	Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice	Lesterhuis, W.J.; Punt, C.J.A.; Hato, S.V.; Eleveld-Trancikova, D.; Jansen, B.J.H.; Nierkens, S.; Schreibelt, G.; Boer, A. de; Herpen, C.M. van; Kaanders, J.H.A.M.; Krieken, J.H. van; Adema, G.J.; Figdor, C.G.; Vries, I.J.M. de
	2011	Cellular angiofibroma: analysis of 25 cases emphasizing its relationship to spindle cell lipoma and mammary-type myofibroblastoma	Flucke, U.E.; Krieken, J.H. van; Mentzel, T.
	2011	Effects of intervention with sulindac and inulin/VSL#3 on mucosal and luminal factors in the pouch of patients with familial adenomatous polyposis	Friederich, P.; Verschuur, J.; Heumen, B.W. van; Schaap-Roelofs, H.M.J.; Berkhout, M.; Nagtegaal, I.D.; Oijen, M.G.H. van; Krieken, J.H. van; Peters, W.H.M.; Nagengast, F.M.
	2011	Identification of candidate predisposing copy number variants in familial and early-onset colorectal cancer patients	Venkatachalam, R.; Verwiel, E.T.P.; Kamping, E.J.; Hoenselaar, E.; Gorgens, H.; Schackert, H.K.; Krieken, J.H. van; Ligtenberg, M.J.L.; Hoogerbrugge, N.; Geurts van Kessel, A.H.M.; Kuiper, R.P.
	2011	KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients	Knijn, N.; Mekenkamp, L.; Klomp, M.; Vink-Borger, M.E.; Tol, J.; Teerenstra, S.; Meijer, J.W.; Tebar, M.; Riemersma, S.; Krieken, J.H. van; Punt, C.J.A.; Nagtegaal, I.D.
	2011	Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation	Jongmans, M.C.J.; Burgt, I. van der; Hoogerbrugge, P.M.; Noordam, K.; Yntema, H.G.; Nillesen, W.M.; Kuiper, R.P.; Ligtenberg, M.J.L.; Geurts van Kessel, A.H.M.; Krieken, J.H. van; Kiemeney, L.A.L.M.; Hoogerbrugge, N.
	2011	Young age and a positive family history of colorectal cancer are complementary selection criteria for the identification of Lynch syndrome	Manders, P.; Spruijt, L.; Kets, C.M.; Willems, H.W.; Bodmer, D.; Hebeda, K.M.; Nagtegaal, I.D.; Krieken, J.H. van; Ligtenberg, M.J.L.; Hoogerbrugge, N.
	2011	Recurrence and variability of germline EPCAM deletions in Lynch syndrome	Kuiper, R.P.; Vissers, L.E.L.M.; Venkatachalam, R.; Bodmer, D.; Hoenselaar, E.; Goossens, M.; Haufe, A.; Kamping, E.J.; Niessen, R.C.; Hogervorst, F.B.L.; Gille, J.J.P.; Redeker, B.; Tops, C.M.; Gijn, M.E. van; Ouweland, A.M. van den; Rahner, N.; Steinke, V.; Kahl, P.; Holinski-Feder, E.; Morak, M.; Kloor, M.; Stemmler, S.; Betz, B.; Hutter, P.; Bunyan, D.J.; Syngal, S.; Culver, J.O.; Graham, T.; Chan, T.L.; Nagtegaal, I.D.; Krieken, J.H. van; Schackert, H.K.; Hoogerbrugge, N.; Geurts van Kessel, A.H.M.; Ligtenberg, M.J.L.
	2011	Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study	Kempers, M.J.E.; Kuiper, R.P.; Ockeloen, C.W.; Chappuis, P.O.; Hutter, P.; Rahner, N.; Schackert, H.K.; Steinke, V.; Holinski-Feder, E.; Morak, M.; Kloor, M.; Buttner, R.; Verwiel, E.T.P.; Krieken, J.H. van; Nagtegaal, I.D.; Goossens, M.; Post, R.S. van der; Niessen, R.C.; Sijmons, R.H.; Kluijt, I.; Hogervorst, F.B.L.; Leter, E.M.; Gille, J.J.P.; Aalfs, C.M.; Redeker, E.J.; Hes, F.J.; Tops, C.M.; Nesselrooij, B.P. van; Gijn, M.E. van; Gomez Garcia, E.B.; Eccles, D.M.; Bunyan, D.J.; Syngal, S.; Stoffel, E.M.; Culver, J.O.; Palomares, M.R.; Graham, T.; Velsher, L.; Papp, J.; Olah, E.; Chan, T.L.; Leung, S.Y.; Geurts van Kessel, A.H.M.; Kiemeney, L.A.L.M.; Hoogerbrugge, N.; Ligtenberg, M.J.L.
	2010	Editorial	Krieken, J.H.J.M. van
	2010	Molecular pathology in contemporary diagnostic pathology laboratory.	Krieken, J.H.J.M. van; Ligtenberg, M.J.L.; Groenen, P.J.T.A.
	2010	New developments in the pathology of malignant lymphoma: a review of the literature published from April 2010-July 2010	Krieken, J.H.J.M. van
	2010	New developments in the pathology of malignant lymphoma: a review of the literature published from August 2010-October 2010	Krieken, J.H.J.M. van
	2010	New developments in the pathology of malignant lymphoma: a review of the literature published from October 2009 to January 2010	Krieken, J.H.J.M. van
	2010	Are we making progress?	Krieken, J.H.J.M. van
	2010	Hematopathology in the new decade : what to expect	Krieken, J.H.J.M. van
	2010	Biomarkers as disease definition: mantle cell lymphoma as an example.	Krieken, J.H.J.M. van; Jansen, C.; Hebeda, K.M.; Groenen, P.J.T.A.
	2010	Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases.	Mekenkamp, L.; Koopman, M.; Teerenstra, S.; Krieken, J.H.J.M. van; Mol, L.; Nagtegaal, I.D.; Punt, C.J.A.
	2010	High sensitivity of both sequencing and real-time PCR analysis of KRAS mutations in colorectal cancer tissue.	Tol, J.; Dijkstra, J.R.; Vink-Borger, M.E.; Nagtegaal, I.D.; Punt, C.J.A.; Krieken, J.H.J.M. van; Ligtenberg, M.J.L.
	2010	Double-staining chromogenic in situ hybridization as a useful alternative to split-signal fluorescence in situ hybridization in lymphoma diagnostics.	Rijk, A. van; Svenstroup-Poulsen, T.; Jones, M.; Cabecadas, J.; Cigudosa, J.C.; Leoncini, L.; Mottok, A.; Bergman, C.C.; Pouliou, E.; Dutoit, S.H.; Krieken, J.H.J.M. van
	2010	Correlation of FCGR3A and EGFR germline polymorphisms with the efficacy of cetuximab in KRAS wild-type metastatic colorectal cancer.	Pander, J.; Gelderblom, H.; Antonini, N.F.; Tol, J.; Krieken, J.H.J.M. van; Straaten, T. van der; Punt, C.J.A.; Guchelaar, H.J.
	2010	Identification of a quantitative MINT locus methylation profile predicting local regional recurrence of rectal cancer.	Maat, M.F. de; Velde, C.J. van de; Benard, A.; Putter, H.; Morreau, H.; Krieken, J.H.J.M. van; Meershoek Klein-Kranenbarg, E.; Graaf, E.J. de; Tollenaar, R.A.E.M.; Hoon, D.S.
	2010	Protein profiling in pathology: analysis and evaluation of 239 frozen tissue biopsies for diagnosis of B-cell lymphomas.	Jansen, C.; Feuth, T.; Raemaekers, J.M.M.; Rijntjes, J.; Meijer, J.W.; Westenend, P.J.; Baarlen, J. van; Krieken, J.H.J.M. van; Hebeda, K.M.; Groenen, P.J.T.A.
	2010	Electronic reminders for pathologists promote recognition of patients at risk for Lynch syndrome: cluster-randomised controlled trial.	Overbeek, L.I.H.; Hermens, R.P.M.G.; Krieken, J.H.J.M. van; Adang, E.M.M.; Casparie, M.; Nagengast, F.M.; Ligtenberg, M.J.L.; Hoogerbrugge-van der Linden, N.
	2010	Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research.	Fitzgerald, R.C.; Hardwick, R.; Huntsman, D.; Carneiro, F.; Guilford, P.; Blair, V.; Chung, D.C.; Norton, J.; Ragunath, K.; Krieken, J.H.J.M. van; Dwerryhouse, S.; Caldas, C.; Hoogerbrugge, N.
	2010	Overlap, common features, and essential differences in pediatric granulomatous inflammatory bowel disease.	Damen, G.M.; Krieken, J.H.J.M. van; Hoppenreijs, E.P.A.H.; Os, E. van; Tolboom, J.J.M.; Warris, A.; Yntema, J.L.; Nieuwenhuis, E.E.; Escher, J.C.
	2010	Improving calculation, interpretation and communication of familial colorectal cancer risk: protocol for a randomized controlled trial.	Dekker, N.; Hermens, R.P.M.G.; Elwyn, G.; Weijden, G.D.E.M. van der; Nagengast, F.M.; Duijvendijk, P. van; Salemink, S.; Adang, E.M.M.; Krieken, J.H.J.M. van; Ligtenberg, M.J.L.; Hoogerbrugge-van der Linden, N.
	2010	Markers for EGFR pathway activation as predictor of outcome in metastatic colorectal cancer patients treated with or without cetuximab.	Tol, J.; Dijkstra, J.R.; Klomp, M.; Teerenstra, S.; Dommerholt, M.; Vink-Borger, M.E.; Cleef, P.H. van; Krieken, J.H.J.M. van; Punt, C.J.A.; Nagtegaal, I.D.
	2010	Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers.	Post, R.S. van der; Kiemeney, L.A.L.M.; Ligtenberg, M.J.L.; Witjes, J.A.; Hulsbergen- van de Kaa, C.A.; Bodmer, D.; Schaap, L.; Kets, C.M.; Krieken, J.H.J.M. van; Hoogerbrugge-van der Linden, N.
	2009	The 2008 WHO-classification: small and big changes!	Krieken, J.H.J.M. van
	2009	The second year of the Journal of Hematopathology has started.	Krieken, J.H.J.M. van
	2009	Yellow-white lesions in the upper gastrointestinal tract. Gastric xanthelasmas.	Jansen, H.J.; Krieken, J.H.J.M. van; Romkens, T.E.H.
	2009	Setting future standards for KRAS testing in colorectal cancer.	Krieken, J.H.J.M. van; Tol, Jolien

1 2 3 4 next